These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Ujike H; Akiyama K; Otsuki S Psychopharmacology (Berl); 1990; 102(4):459-64. PubMed ID: 2151400 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characteristics of hyperambulation induced by the sigma ligand (+)-3-PPP in rats. Hirotsu I; Koyama M; Honbo N; Ohno T Jpn J Pharmacol; 1994 May; 65(1):1-7. PubMed ID: 7916383 [TBL] [Abstract][Full Text] [Related]
7. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor. Earley B; Burke M; Leonard BE; Gouret CJ; Junien JL Brain Res; 1991 Apr; 546(2):282-6. PubMed ID: 1676927 [TBL] [Abstract][Full Text] [Related]
8. (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine binding to sigma receptors in mouse brain in vivo. Koe BK; Burkhart CA; Lebel LA Eur J Pharmacol; 1989 Feb; 161(2-3):263-6. PubMed ID: 2566491 [TBL] [Abstract][Full Text] [Related]
9. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice. Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of potassium currents by the sigma receptor ligand (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine in sympathetic neurons of the mouse isolated hypogastric ganglion. Kennedy C; Henderson G Neuroscience; 1990; 35(3):725-33. PubMed ID: 1974331 [TBL] [Abstract][Full Text] [Related]
11. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats. Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612 [TBL] [Abstract][Full Text] [Related]
12. Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands. Rao TS; Mick SJ; Cler JA; Emmett MR; Dilworth VM; Contreras PC; Gray NM; Wood PL; Iyengar S Brain Res; 1991 Oct; 561(1):43-50. PubMed ID: 1686745 [TBL] [Abstract][Full Text] [Related]
13. Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple sigma binding sites. Itzhak Y; Stein I Brain Res; 1991 Dec; 566(1-2):166-72. PubMed ID: 1667608 [TBL] [Abstract][Full Text] [Related]
14. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305 [TBL] [Abstract][Full Text] [Related]
15. Sigma receptor modulation of the muscle relaxant action of eperisone. Hasegawa Y; Kaku S; Araki H; Otomo S Eur Neuropsychopharmacol; 1992 Jun; 2(2):157-9. PubMed ID: 1353001 [TBL] [Abstract][Full Text] [Related]
16. Sigma-receptors: implication for the control of neuronal activity of nigral dopamine-containing neurons. Engberg G; Wikström H Eur J Pharmacol; 1991 Aug; 201(2-3):199-202. PubMed ID: 1686758 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Steinfels GF; Tam SW; Cook L Neuropsychopharmacology; 1989 Sep; 2(3):201-8. PubMed ID: 2571340 [TBL] [Abstract][Full Text] [Related]
18. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide. Landa L; Jurajda M; Sulcova A Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253 [TBL] [Abstract][Full Text] [Related]
19. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization]. Muraki A Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937 [TBL] [Abstract][Full Text] [Related]